Target intelligence / Profile preview

Paracrine pathway modulation

Molecular classification
Other
01

Overview

Paracrine pathway modulation refers to the therapeutic intervention in signaling processes where a cell produces a signal to induce changes in nearby cells, altering the behavior of those cells [1]. Unlike endocrine signaling, which uses the circulatory system to transport ligands, paracrine signals diffuse through the extracellular matrix to act locally [2]. This form of communication is critical in maintaining tissue homeostasis, regulating immune responses, and directing embryonic development [3]. In disease states like cancer, aberrant paracrine signaling—such as the secretion of growth factors by stromal cells to support tumor growth—is a major driver of progression and drug resistance [4]. Modulating these pathways often involves targeting secreted ligands (e.g., cytokines, chemokines, or growth factors) or their respective receptors on adjacent cells to disrupt pathological local environments [5, 6]. Sources: [1] NCI Dictionary of Cancer Terms; [2] Alberts B, et al., Molecular Biology of the Cell; [3] Gilbert SF, Developmental Biology; [4] Hanahan D, Weinberg RA, Cell 2011; [5] Teicher BA, Fricker SP, Clin Cancer Res 2010; [6] Ferrara N, et al., Nature Reviews Drug Discovery 2004.

Other names
Paracrine signalingLocal cell signalingNeighbor signalingStromal-epithelial crosstalkCell-to-cell communication
02

Mechanism of action

Disruption of local signaling by neutralizing secreted ligands or blocking their cognate receptors on adjacent cells to interrupt pathological feedback loops [1, 5].

03

Biological functions

Signal transductionCell-to-cell communicationTissue homeostasisDevelopmentImmune response
04

Disease associations

CancerInflammationFibrosisCardiovascular diseaseAutoimmune disease
05

Safety considerations

Systemic toxicity from inhibiting homeostatic local signalingImpaired tissue repair and wound healingPotential for compensatory pathway activationOff-target effects on non-diseased tissues
06

Interacting drugs

Bevacizumab

4 more in the full profile.

07

Biomarkers

Local cytokine concentrationLigand expression in tissue biopsiesPhosphorylation of downstream effectors in neighboring cells (e.g., p-STAT3, p-SMAD)

Beyond the preview

Go deeper on Paracrine pathway modulation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Paracrine pathway modulation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call